what is basal insulin analogue
Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba.[1] It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes.he amino acid sequence of animal insulins in different mammals may be similar to human insulin (insulin human INN), there is however considerable viability within vertebrate species.